Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.930
+0.110 (6.04%)
Jan 22, 2026, 9:38 AM EST - Market open
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $159.03 million as of January 22, 2026. Its market cap has increased by 50.80% in one year.
Market Cap
159.03M
Enterprise Value
112.86M
1-Year Change
50.80%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $159.03M, a decrease of -80.29%. That is a compound annual growth rate of -26.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 149.96M | -37.24% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 162.81M |
| Corbus Pharmaceuticals Holdings | 159.16M |
| Opus Genetics | 155.86M |
| Surrozen | 154.11M |
| Tenaya Therapeutics | 152.03M |
| Molecular Partners AG | 151.55M |
| Codexis | 145.42M |
| Nkarta | 144.90M |